CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 15 enrolled
Drug / intervention
Gadolinium-Chelate +3 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04870645
NCT04870645N/ACompleted

Advanced MRI for Intracranial Metastasis Treated With Stereotactic Radiosurgery

M.D. Anderson Cancer Center·interventional·Posted May 3, 2021·Updated Nov 6, 2024

In Brief

A clinical study evaluating Advanced Magnetic Resonance Imaging, Conventional Magnetic Resonance Imaging, and 2 other interventions for Malignant Solid Neoplasm. Completed, enrolled 15 participants across 1 site.

Detailed Summary

This clinical trial studies the different types of investigational imaging techniques called sequences during magnetic resonance imaging (MRI) of the head before and after radiation therapy in patients with cancer that has spread to the brain (intracranial metastases). This clinical trial also compares these new techniques with standard MRI imaging to see if sequences provide better images. Diagnostic procedures, such as MRI, may help find and diagnose solid organ cancer and find out how far the disease has spread.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
20222023202420252026
First PostedMay 3, 2021
Enrollment StartMar 30, 2021
Primary CompletionAug 29, 2023
TodayJul 2, 2026
Enrollment to primary: 2.4 yearsPosted 5.2 years ago

Interventions

Advanced Magnetic Resonance Imagingprocedure

Undergo advanced MRI

Conventional Magnetic Resonance Imagingprocedure

Undergo conventional MRI

Gadolinium-Chelatedrug

Contrast agent

Iopamidoldrug

Contrast agent